CVS Group plc,
United Kingdom · GB00B2863827 · reports in GBP · Europe
The answers
From the annual report for the year to Jun 30, 2026. Each line says what it is based on.
- Is it growing?Fair
- Revenue +5.9% in the year to Jun 30, 2026, on the year before.
- Is it a good business?Fair
- It earned 6.0% on its shareholders' equity in the year to Jun 30, 2026.
- Is it safe?Fair
- Equity is 38% of its assets, and operations brought in cash in the year.
- Is the price fair?n/a
- Not answered: no exchange publishes this company's price for free reuse, so there is no P/E here.
The year
Year to Jun 30, 2026, consolidated, in GBP.
revenue
operating margin
net profit
Year by year
As filed; an earlier year can differ from its own report when the company restated it.
| Jun 2025 | Jun 2026 | |
|---|---|---|
| Revenue | £6.7B | £7.1B |
| Operating profit | £498M | £476M |
| Net profit to shareholders | £528M | £173M |
| Cash from operations | £821M | £713M |
| Capital spending | £264M | £285M |
| Cash | £161M | £184M |
| Total assets | £7.0B | £7.7B |
| Equity | £3.0B | £3.0B |
What they do
In the company's own words, from the annual report.
The principal activity of CVS Group plc, together with its subsidiaries (the Group), is to operate veterinary practices, complementary veterinary diagnostic businesses and an online pharmacy and retail business. The principal activity of CVS Group plc (the Company) is that of a holding company.
Source: the company’s annual financial report in ESEF, via filings.xbrl.org (XBRL International). Listed shares from ESMA’s FIRDS register; ESMA does not endorse this site. Ryufin computed the answers and ratios from the filed figures.